SELLAS Life Sciences (SLS) Total Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 6 years of Total Debt data on file, last reported at $76000.0 in Q3 2018.

• Quarterly Total Debt fell 99.38% year-over-year to $76000.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $76000.0 (down 99.38% YoY) and the FY2017 annual result came in at $11.0 million, up 542.95% from the prior year.
• Total Debt slipped to $76000.0 in Q3 2018 per SLS's latest filing, from $7.8 million in the prior quarter.
• Across five years, Total Debt topped out at $23.7 million in Q3 2016 and bottomed at $76000.0 in Q3 2018.
• The 5-year median for Total Debt is $9.3 million (2014), against an average of $9.5 million.
• The widest annual swing landed in 2017, when Total Debt surged 542.95%; it then sank 99.38% in 2018.
• Tracing SLS's Total Debt over 5 years: stood at $8.4 million in 2014, then slumped by 43.6% to $4.7 million in 2015, then sank by 63.94% to $1.7 million in 2016, then surged by 542.95% to $11.0 million in 2017, then slumped by 99.31% to $76000.0 in 2018.
• Per Business Quant, the three latest SLS Total Debt figures stand at $76000.0 (Q3 2018), $7.8 million (Q2 2018), and $9.7 million (Q1 2018).

Peer Comparison